BioMarin Pharma (BMRN) Tops Q1 EPS by 39c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $66.99 +0.53%
Financial Fact:
Interest income: 1.63M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Interest income: 1.63M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q1 EPS of $0.60, $0.39 better than the analyst estimate of $0.21. Revenue for the quarter came in at $596.4 million versus the consensus estimate of $571.33 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
- BioMarin to acquire Alesta Therapeutics for $275M upfront
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
